Suppr超能文献

可溶性尿激酶型纤溶酶原激活物受体与中国年轻冠心病患者的风险。

Soluble Urokinase Plasminogen Activator Receptor and the Risk of Coronary Artery Disease in Young Chinese Patients.

机构信息

Department of Cardiology, Shunde Hospital, Southern Medical University, Foshan, China.

Department of Cardiology, Nanfang Hospital of Southern Medical University, Guangzhou 510515, China.

出版信息

Dis Markers. 2017;2017:4719403. doi: 10.1155/2017/4719403. Epub 2017 Oct 4.

Abstract

BACKGROUND

Soluble urokinase plasminogen activator receptor (suPAR) is a novel marker of chronic inflammation and is considered to be a risk factor for coronary artery disease (CAD) in Caucasians. This study investigated the role of suPAR in young Chinese patients with CAD.

METHODS

The study involved a total of 196 consecutive young (age ≤ 55 years) patients with angiographically proven CAD and 188 age-matched non-CAD individuals as controls. Traditional risk factors were evaluated using conventional assays, and levels of suPAR were measured by sandwich enzyme-linked immunosorbent assays.

RESULTS

Levels of suPAR were significantly correlated with age ( = 0.20, = 0.04), smoking ( = 0.33, = 0.008), body mass index ( = 0.21, = 0.03), and high-sensitivity C-reactive protein (hs-CRP; = 0.31, = 0.01). Multivariate logistic regression analysis showed that male sex (odds ratio (OR) = 3.12; 95% confidence interval (CI) = 1.18-8.25, = 0.02), smoking (OR = 3.41, 95% CI = 1.55-7.50, = 0.002), triglyceride (OR = 1.89, 95% CI = 1.10-3.25, = 0.02), high-sensitivity C-reactive protein (OR = 1.24, 95% CI = 1.02-0.03, = 0.03), and suPAR (OR = 1.37, 95% CI = 1.09-1.72, = 0.007) were independently associated with CAD risk in young patients.

CONCLUSIONS

SuPAR is a novel independent risk factor for CAD in young Chinese patients. Further studies evaluating the effect of anti-inflammatory treatment on the suPAR levels and the risk of CAD are needed.

摘要

背景

可溶性尿激酶型纤溶酶原激活物受体(suPAR)是一种新型的慢性炎症标志物,被认为是高加索人群中冠心病(CAD)的危险因素。本研究旨在探讨 suPAR 在年轻的中国 CAD 患者中的作用。

方法

本研究共纳入 196 例经血管造影证实的年轻(年龄≤55 岁)CAD 患者和 188 例年龄匹配的非 CAD 个体作为对照组。采用常规检测方法评估传统危险因素,夹心酶联免疫吸附试验检测 suPAR 水平。

结果

suPAR 水平与年龄( = 0.20, = 0.04)、吸烟( = 0.33, = 0.008)、体重指数( = 0.21, = 0.03)和高敏 C 反应蛋白(hs-CRP; = 0.31, = 0.01)显著相关。多变量 logistic 回归分析显示,男性(比值比(OR)=3.12;95%置信区间(CI)=1.18-8.25, = 0.02)、吸烟(OR=3.41,95% CI=1.55-7.50, = 0.002)、甘油三酯(OR=1.89,95% CI=1.10-3.25, = 0.02)、高敏 C 反应蛋白(OR=1.24,95% CI=1.02-0.03, = 0.03)和 suPAR(OR=1.37,95% CI=1.09-1.72, = 0.007)与年轻患者 CAD 风险独立相关。

结论

suPAR 是中国年轻 CAD 患者的一种新的独立危险因素。需要进一步研究评估抗炎治疗对 suPAR 水平和 CAD 风险的影响。

相似文献

3
Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes.
Atherosclerosis. 2017 Sep;264:108-114. doi: 10.1016/j.atherosclerosis.2017.06.019. Epub 2017 Jun 8.
7
SuPAR is associated with death and adverse cardiovascular outcomes in patients with suspected coronary artery disease.
Scand Cardiovasc J. 2020 Dec;54(6):339-345. doi: 10.1080/14017431.2020.1762917. Epub 2020 May 13.

引用本文的文献

1
Correlation of non-esterified fatty acids with acute coronary syndrome risk in young Chinese adults.
Front Endocrinol (Lausanne). 2025 Jun 6;16:1479497. doi: 10.3389/fendo.2025.1479497. eCollection 2025.
3
Soluble Urokinase Plasminogen Activator Receptor as a Diagnostic and Prognostic Biomarker in Cardiac Disease.
J Clin Med Res. 2021 Mar;13(3):133-142. doi: 10.14740/jocmr4459. Epub 2021 Mar 19.
4
Risk factors for coronary artery disease in young patients with stable angina pectoris.
Turk J Med Sci. 2019 Aug 8;49(4):993-998. doi: 10.3906/sag-1905-56.
5
Gamma-Glutamyltransferase and Risk of Acute Coronary Syndrome in Young Chinese Patients: A Case-Control Study.
Dis Markers. 2018 Sep 2;2018:2429160. doi: 10.1155/2018/2429160. eCollection 2018.
6
Soluble Urokinase Plasminogen Activator Receptor (suPAR) and All-Cause and Cardiovascular Mortality in Diverse Hemodialysis Patients.
Kidney Int Rep. 2018 May 22;3(5):1100-1109. doi: 10.1016/j.ekir.2018.05.004. eCollection 2018 Sep.

本文引用的文献

1
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.
3
Differing Clinical Characteristics Between Young and Older Patients Presenting with Myocardial Infarction.
Heart Lung Circ. 2017 Jun;26(6):566-571. doi: 10.1016/j.hlc.2016.09.007. Epub 2016 Nov 11.
5
Myocardial Infarction in the "Young": Risk Factors, Presentation, Management and Prognosis.
Heart Lung Circ. 2016 Oct;25(10):955-60. doi: 10.1016/j.hlc.2016.04.015. Epub 2016 May 16.
6
Coronary Computed Tomography Angiography in the Evaluation of Chest Pain of Suspected Cardiac Origin.
Circulation. 2016 May 17;133(20):1963-8. doi: 10.1161/CIRCULATIONAHA.116.017593.
9
Plasma suPAR is lowered by smoking cessation: a randomized controlled study.
Eur J Clin Invest. 2016 Apr;46(4):305-11. doi: 10.1111/eci.12593. Epub 2016 Feb 19.
10
Sex Versus Gender-Related Characteristics: Which Predicts Outcome After Acute Coronary Syndrome in the Young?
J Am Coll Cardiol. 2016 Jan 19;67(2):127-135. doi: 10.1016/j.jacc.2015.10.067.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验